Venkata Alla is a Cardiology physician affiliated with Creighton University. OpenAlex indexes 255 publications with 1,830 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7500 Mercy Rd
Omaha, NE 68124
Telephone
402-398-5880Registry record last updated 9 Oct 2018.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.9%Beta blocker23.6%Metoprolol Succinate45%Carvedilol34%Metoprolol Tartrate17%Nebivolol Hcl3%Nadolol2%Part D<11 patientsStatin16.1%Atorvastatin Calcium74%Rosuvastatin Calcium19%Pravastatin Sodium4%Simvastatin3%Part D<11 patients+ 13 more classes in this area
Blood & clotting
13%Factor Xa inhibitor8.8%Eliquis73%Xarelto27%Part D≥45 patientsP2Y12 inhibitor2.4%Clopidogrel83%Brilinta17%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.1%Potassium supplement3.3%Potassium Chloride79%Klor-Con M2021%Part D<11 patientsSGLT2 inhibitor2.8%Jardiance100%Part D≥23 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication
JACC: Cardiovascular Interventions
2024 - Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure
JACC: Cardiovascular Interventions
2023 - Transcatheter vacuum aspiration of valvular and lead related infective endocarditis
Cardiovascular revascularization medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Beart, MD
Creighton University
Alan Thorson, MD
Creighton University
Aryan Mooss, MD
Creighton University
Ross Bremner, MD
Creighton University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”